25.01.2013 Views

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

106 6 <strong>Immune</strong> Cells in the Tumor Microenvironment<br />

[61]. Furthermore, a division of labor exists among DCs, in that immature CD83 ±<br />

DC are primarily responsible for antigen uptake, while mature CD83 + DC are excellent<br />

APCs [61]. Several reports showed that DC obtained from peripheral blood<br />

mononuclear cells of patients with cancer had lower than normal expression of<br />

HLA-DR <strong>and</strong> co-stimulatory molecules, <strong>and</strong> had depressed stimulatory activity [54,<br />

62]. Our own recent studies in patients with head <strong>and</strong> neck cancer indicated that<br />

while the percentage of total LIN-DR + DC was comparable in the circulation of patients<br />

<strong>and</strong> controls (1.6 versus 1.5%), DR expression on individual DCs was clearly<br />

decreased in patients relative to that in control DC [63]. When we determined the<br />

proportions of LIN-DR + CD123 + versus LIN-DR + CD11c + subsets of DCs in the circulation<br />

<strong>by</strong> multicolor flow cytometry, we found that myeloid-derived DCs were significantly<br />

depleted in patients compared to controls [63]. After tumor surgery, significant<br />

normalization of the proportion of myeloid DCs was observed. These data suggest<br />

that an imbalance in DC subsets <strong>and</strong> the paucity of co-stimulatory molecules on DC<br />

are consequences of the malignancy, <strong>and</strong> mechanisms responsible for these alterations<br />

are under investigation.<br />

The data on functional impairments of TADC have to be balanced <strong>by</strong> numerous reports<br />

in the literature, which suggest that the presence of DCs in tumors is associated<br />

with improved prognosis [64, 65]. DC infiltrations into tumors have been associated<br />

with significantly prolonged patient survival, <strong>and</strong> reduced incidence of recurrent<br />

or metastatic disease in patients with bladder, lung, laryngeal, oral, gastric <strong>and</strong><br />

nasopharyngeal carcinomas [66±72]. In contrast, patients with lesions reported to be<br />

scarcely infiltrated with DC had a relatively poor prognosis [73]. Fewer DC were observed<br />

in metastatic than primary lesions [74]. In a recent study, we demonstrated<br />

that the number of S-100 + DC present in the tumor was <strong>by</strong> far the strongest independent<br />

predictor of overall survival as well as disease-free survival <strong>and</strong> time to recurrence<br />

in 132 patients with oral carcinoma, compared with such well-established<br />

prognostic factors as disease stage or lymph node involvement [65]. Another striking<br />

observation we made concerns the relationship between the number of DC in the tumor<br />

<strong>and</strong> expression of the TCR-associated z chain in TIL. The paucity of DC in the<br />

tumor was significantly related to the loss of z expression in TIL <strong>and</strong> these two factors<br />

had a highly significant effect on patient overall survival. As illustrated in Fig.<br />

6.7, the poorest survival <strong>and</strong> the greatest risk was observed in patients with tumors<br />

that had small number of DC <strong>and</strong> little or no z expression in TIL (p = 2.4 × 10 ±8 ).<br />

These data suggest that both the number of DC <strong>and</strong> the presence of functionally unimpaired<br />

T cells in the tumor microenvironment are important for overall survival of<br />

patients with cancer. Interactions of DC <strong>and</strong> T cells in the tumor appear to sustain<br />

TCR-mediated, <strong>and</strong> presumably tumor-directed, functions of the T cells infiltrating<br />

the same area. It is possible that DC protect T cells from tumor-induced immune<br />

suppression, although the mechanism responsible for such protection remains unknown.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!